Delta Capital Management LLC Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Delta Capital Management LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 7,250 shares of the healthcare conglomerate’s stock after purchasing an additional 60 shares during the quarter. UnitedHealth Group makes up about 1.4% of Delta Capital Management LLC’s holdings, making the stock its 16th largest position. Delta Capital Management LLC’s holdings in UnitedHealth Group were worth $3,667,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group during the 3rd quarter worth $27,000. Global Wealth Strategies & Associates increased its position in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. West Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at approximately $32,000. Quarry LP raised its stake in shares of UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 37 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the 3rd quarter worth $37,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.1 %

Shares of NYSE:UNH opened at $510.03 on Monday. The firm has a market capitalization of $469.37 billion, a P/E ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day moving average of $549.37 and a two-hundred day moving average of $563.18.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.83 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Piper Sandler reduced their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. TD Cowen upped their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. KeyCorp restated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a report on Friday. Finally, Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Two analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.